Investing
Investing Cash Flow
Revolution Medicines, Inc. Investing Cash Flow increased by 130.5% to $172.62M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1182.3%, from -$15.95M to $172.62M. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows an upward trend with a -5.9% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2018
Last reportedQ1 2026May 6, 2026
How to read this metric
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
Detailed definition
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Peer comparison
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
Metric ID:
net_cash_from_investingHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$122.78M | -$30.18M | $0.00 | $44.03M | $62.40M | -$123.44M | -$7.10M | $4.00M | -$43.54M | $77.35M | -$380.40M | -$247.97M | $107.94M | -$21.47M | -$392.90M | -$15.95M | $34.28M | $24.85M | $74.88M | $172.62M |
| QoQ Change | — | +75.4% | +100.0% | — | +41.7% | -297.8% | +94.2% | +156.3% | <-999% | +277.6% | -591.8% | +34.8% | +143.5% | -119.9% | <-999% | +95.9% | +314.9% | -27.5% | +201.3% | +130.5% |
| YoY Change | — | — | — | — | +150.8% | -309.0% | — | -90.9% | -169.8% | +162.7% | <-999% | <-999% | +347.9% | -127.8% | -3.3% | +93.6% | -68.2% | +215.7% | +119.1% | >999% |
Range-$392.90M – $172.62M
CAGR+7.4%
Avg YoY Growth-670.5%
Median YoY Growth-3.3%
Current Streak2 quarters growth
Investing Cash Flow at Other Companies
Frequently Asked Questions
- What is Revolution Medicines, Inc.'s investing cash flow?
- Revolution Medicines, Inc. (RVMD) reported investing cash flow of $172.62M in Q1 2026.
- How has Revolution Medicines, Inc.'s investing cash flow changed year-over-year?
- Revolution Medicines, Inc.'s investing cash flow increased by 1182.3% year-over-year, from -$15.95M to $172.62M.
- What is the long-term trend for Revolution Medicines, Inc.'s investing cash flow?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s investing cash flow has grown at a -5.9% compound annual growth rate (CAGR), from -$150.65M to $118.06M.
- What does investing cash flow mean?
- The net amount of cash spent on or received from investing activities.